Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
- Conditions
- Interventions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1500
- Registration Number
- NCT00899223
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸Illinois CancerCare - Canton, Canton, Illinois, United States
🇺🇸Eureka Community Hospital, Eureka, Illinois, United States
Study of Tumor Samples From Patients With Lung Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 280
- Registration Number
- NCT00900328
- Locations
- 🇺🇸
University of Chicago, Boston, Massachusetts, United States
Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 60
- Registration Number
- NCT00898924
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1195
- Registration Number
- NCT00897026
- Locations
- 🇺🇸
Washington University, Saint Louis, Missouri, United States
Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
- Conditions
- Interventions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 451
- Registration Number
- NCT00896701
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸Kinston Medical Specialists, Kinston, North Carolina, United States
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
- Conditions
- Interventions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2019-01-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 47
- Registration Number
- NCT00898547
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 600
- Registration Number
- NCT00898456
- Locations
- 🇺🇸
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer
- Conditions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1500
- Registration Number
- NCT00899509
- Locations
- 🇺🇸
Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States
🇺🇸Mercy Medical Center - Sioux City, Sioux City, Iowa, United States
🇺🇸St. Luke's Regional Medical Center, Sioux City, Iowa, United States
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
- Conditions
- Interventions
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 144
- Registration Number
- NCT00892177
- Locations
- 🇺🇸
Kauai Medical Clinic, Lihue, Hawaii, United States
🇺🇸Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States
🇺🇸Castle Medical Center, Kailua, Hawaii, United States
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
- Conditions
- Interventions
- First Posted Date
- 2009-05-01
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 12
- Registration Number
- NCT00891878
- Locations
- 🇺🇸
Memorial Hospital, Carthage, Illinois, United States
🇺🇸Graham Hospital, Canton, Illinois, United States
🇺🇸Illinois CancerCare - Havana, Havana, Illinois, United States